Reviews on Recent Clinical Trials
Title:Meet Our Editorial Board Member:
Volume: 10 Issue: 1
Author(s): Ludovico Abenavoli
Affiliation:
Export Options
About this article
Cite this article as:
Abenavoli Ludovico, Meet Our Editorial Board Member:, Reviews on Recent Clinical Trials 2015; 10 (1) . https://dx.doi.org/10.2174/157488711001150521120703
DOI https://dx.doi.org/10.2174/157488711001150521120703 |
Print ISSN 1574-8871 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-1038 |
21
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Patents on Transglutaminase Production and Applications: A Brief Review
Recent Patents on Biotechnology Recent Developments in Targeting Breast Cancer Stem Cells
Recent Patents on Regenerative Medicine Selective Antagonism at Dopamine D3 Receptors as a Target for Drug Addiction Pharmacotherapy: A Review of Preclinical Evidence
CNS & Neurological Disorders - Drug Targets Incorporating Coping into an Expectancy Framework for Explaining Drinking Behaviour
Current Drug Abuse Reviews Probing an Artificial Polypeptide Receptor Library Using a Series of Novel Histamine H3 Receptor Ligands
Combinatorial Chemistry & High Throughput Screening Editorial [Is Suicidality Serious?]
Current Drug Safety Aldose Reductase Enzyme and its Implication to Major Health Problems of the 21st Century
Current Medicinal Chemistry Mitochondria-Associated Membranes (MAMs): A Novel Therapeutic Target for Treating Metabolic Syndrome
Current Medicinal Chemistry Molecular Interaction of the Antineoplastic Drug, Methotrexate with Human Brain Acetylcholinesterase: A Docking Study
CNS & Neurological Disorders - Drug Targets Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) The Phosphodiesterase III Inhibitor Cilostazol Ameliorates Ethanolinduced Endothelial Dysfunction
Current Neurovascular Research Non-coding RNAs: Cracking the Code for Clinical Disease
Current Neurovascular Research Clinical Science of Calcium Channel Blocker to Inhibit Hypertensive Vascular Injury
Current Hypertension Reviews The State of the Art on the Use of Oral Fluid as Alternative Specimen in Forensic Toxicology
Current Pharmaceutical Analysis C5a, a Therapeutic Target in Sepsis
Recent Patents on Anti-Infective Drug Discovery Toll-Like Receptors and Myocardial Ischemia/Reperfusion, Inflammation, and Injury
Current Cardiology Reviews Role of Complement Systems in IVIG Mediated Attenuation of Cognitive Deterioration in Alzheimer's Disease
Current Alzheimer Research Analysis of Genetic Variants in SCN1A, SCN2A, KCNK18, TRPA1 and STX1A as a Possible Marker of Migraine
Current Genomics Identification of an Amyloidogenic Peptide From the Bap Protein of Staphylococcus epidermidis
Protein & Peptide Letters Chromatin Remodeling, DNA Damage Repair and Aging
Current Genomics